X4 Pharmaceuticals Inc (XFOR) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
X4 Pharmaceuticals Inc  (NASDAQ: XFOR)
 

X4 Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, X4 Pharmaceuticals Inc's inventory turnover ratio sequentially decreased to 0.61 in the third quarter 2026, unsurprisingly, as the X4 Pharmaceuticals Inc markets continue to deteriorate, and XFOR's faces growing challenges to bring down its inventories. X4 Pharmaceuticals Inc's average inventory processing period in the Sep 30 2026 quarter, has increased to 598 days, from 579 days, in the Jun 30 2026 quarter.

Within Healthcare sector 344 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1787 in the second quarter 2026, to 1920.

XFOR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is X4 Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XFOR Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 34.98 % 73.56 % 50.11 % 59 % 66.87 %
Y / Y Cost of Sales Growth 46.15 % 396.01 % -87.32 % 20.53 % 54.63 %
Inventory Turnover Ratio (TTM) 0.61 0.63 0.4 1.55 1.73
XFOR's Total Ranking # 1920 # 1787 # 1386 # 1033 #
Average inventory processing period 594 582 911 235 211
Seq. Inventory Growth 0.09 % 18.65 % 3.53 % 9.78 % 28.71 %
Seq. Cost of Sales Growth -68.27 % 170.4 % 64.29 % 3.7 % 7.67 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 345
Overall Market # 1920

Inventory Turnover Ratio Statistics
High Average Low
2.4 1.44 0.4
(Mar 31 2025)   (Mar 31 2026)



XFOR Company Profile >> Back to XFOR Efficiency Comparisons >> Compare XFOR Inventory Turnover Ratio to its Competitors

Financial Statements
X4 Pharmaceuticals Inc's Inventories $ 6 Millions Visit XFOR's Balance sheet
X4 Pharmaceuticals Inc's Cost of Revenues TTM $ 3 Millions Visit XFOR's Income Statement
What are XFOR's Sales? Visit XFOR's Sales by Segment

Other Inventory Turnover Ratios
X4 Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XFOR's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XFOR's Competitors
Inventory Turnover Ratio for XFOR's Suppliers
Inventory Turnover Ratio for XFOR's Customers

You may also want to know
XFOR's Sales Growth Rates XFOR's Pe Price to earnings ratio XFOR's Receivables Turnover Ratio XFOR's Stock Quote
XFOR's Net Income Growth Rates XFOR's Ps Price to Sales ratio XFOR's Sales per Employee XFOR's Asset Turnover Ratio
XFOR's Net Margin XFOR's Pb Price to Book ratio XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Mannkind Corporation  1.16 $ 51.332  Millions$ 44  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Teleflex Incorporated  1.12 $ 427.166  Millions$ 380  Millions
Acadia Pharmaceuticals Inc   1.12 $ 114.422  Millions$ 102  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions
Vertex Pharmaceuticals Inc  1.00 $ 1,874.100  Millions$ 1,866  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Rxsight Inc   0.82 $ 29.342  Millions$ 36  Millions
Profound Medical Corp   0.79 $ 6.177  Millions$ 8  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions
Butterfly Network Inc   0.62 $ 37.120  Millions$ 60  Millions
Regeneron Pharmaceuticals Inc   0.60 $ 1,842.200  Millions$ 3,071  Millions
Lenz Therapeutics Inc   0.58 $ 2.228  Millions$ 4  Millions
Lexicon Pharmaceuticals Inc   0.58 $ 0.427  Millions$ 1  Millions
Biomarin Pharmaceutical Inc  0.57 $ 878.919  Millions$ 1,538  Millions
Verastem Inc   0.51 $ 1.117  Millions$ 2  Millions

Date modified: 2026-11-06T12:59:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.